Crucell Articles

Crucell and Scripps Research discover broad-spectrum antibodies against influenza B

12 August 2012

Vaccines collaborations by Biovest and US Army and by ARTES and Crucell

24 April 2012

PATH MVI partners with GSK and Crucell to develop second-generation vaccine against malaria

8 June 2011

Pepscan closes vaccines deal with Crucell; Update on J&J takeover

11 March 2011

Crucell M&A update; Meda buys Antula; Bayer eyes pharma boost

22 February 2011

Johnson & Johnson moves forward with 24.75-euro bid for full control of Crucell

9 December 2010

Bayer buys rights to “female Viagra” for C$330 million; Johnson & Johnson proceeds with $2.42 billion bid for Crucell

6 October 2010

Johnson & Johnson plans to take full control of Crucell for around $2.29 billion

17 September 2010

Sanofi-Aventis unit returns rights for pediatric and respiratory vaccines to Crucell; invests $65 million to expand in USA

9 July 2010

GlaxoSmithKline sees UK govt order for pandemic vaccine slashed; enters malaria vaccine deal with Crucell

7 April 2010

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end